Latest filing published 23 May 2014 for CTI Biopharma CORP.
Insider track record
No signal scores available.
Karen Ignagni: trading record in brief
Karen Ignagni discloses dealings in CTI Biopharma Corp to SEC (Form 4). The record holds 2 filings, for trades running from 31 January 2014 to 22 May 2014.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 23 May 2014 came the latest disclosure, a share grant in CTI Biopharma Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Karen Ignagni
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 34,844 shares0Common StockSEC:0000891293-14-000012:0
- 31,348 shares0Common StockSEC:0001209191-14-006658:0
2 of 2 declarations
